Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome:  A randomized, placebo‐controlled clinical trial

Mahsa Gholizadeh‐Moghaddam; Hatav Ghasemi‐Tehrani; Gholamreza Askari; Mahsima Jaripur; Cain C. T. Clark; Mohammad Hossein Rouhani

doi:10.1002/hsr2.1013

Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial

Mahsa Gholizadeh‐Moghaddam, Hatav Ghasemi‐Tehrani, Gholamreza Askari, Mahsima Jaripur, Cain C. T. Clark, Mohammad Hossein Rouhani

Isfahan University of Medical Sciences

Research output: Contribution to journal › Article › peer-review

14 Downloads (Pure)

Abstract

Background and Aims: Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to examine the effects of magnesium supplementation on hyperandrogenism, hirsutism, and sleep quality in women with PCOS. Methods: In this parallel randomized clinical trial, 64 women with PCOS were randomly assigned to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. Patients in the magnesium group received one 250 mg magnesium oxide tablet, per day. Hyperandrogenism, hirsutism, and sleep quality were measured at the beginning and end of the study. This randomized clinical trial was registered at https://www.IRCT.ir (IRCT20130903014551N8). Results: Magnesium supplementation had no significant effect on hyperandrogenism (p = 0.51 for dehydroepiandrosterone sulfates, p = 0.27 for testosterone), hirsutism (p = 0.23), and sleep quality (p = 0.85) compared with placebo. Conclusions: The present study showed that a single dose of magnesium supplementation elicited no beneficial effects on the mentioned symptoms in polycystic women. It is possible that the positive effects of magnesium observed in the former studies were due to the synergistic effects of other vitamins or minerals. More studies are needed in this area.

Original language	English
Article number	e1013
Number of pages	8
Journal	Health Science Reports
Volume	6
Issue number	1
Early online date	29 Dec 2022
DOIs	https://doi.org/10.1002/hsr2.1013
Publication status	Published - Jan 2023

Bibliographical note

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited.© 2022 The Authors.Health Science Reportspublished by Wiley Periodicals LLC.

Keywords

hirsutism
hyperandrogenism
magnesium
polycystic ovarian syndrome
sleep quality

Access to Document

10.1002/hsr2.1013Licence: CC BY

PublishedFinal published version, 1.43 MBLicence: CC BY
Health Science Reports - 2022 - Gholizadeh‐Moghaddam - Effect of magnesium supplementation in improving hyperandrogenism Final published version, 1.01 MBLicence: CC BY

Cite this

Gholizadeh‐Moghaddam, M., Ghasemi‐Tehrani, H., Askari, G., Jaripur, M., Clark, C. C. T., & Rouhani, M. H. (2023). Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial. Health Science Reports, 6(1), [e1013]. https://doi.org/10.1002/hsr2.1013

Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome : A randomized, placebo‐controlled clinical trial. / Gholizadeh‐Moghaddam, Mahsa; Ghasemi‐Tehrani, Hatav; Askari, Gholamreza et al.

In: Health Science Reports, Vol. 6, No. 1, e1013, 01.2023.

Research output: Contribution to journal › Article › peer-review

Gholizadeh‐Moghaddam, M, Ghasemi‐Tehrani, H, Askari, G, Jaripur, M, Clark, CCT & Rouhani, MH 2023, 'Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial', Health Science Reports, vol. 6, no. 1, e1013. https://doi.org/10.1002/hsr2.1013

@article{c945421f370845a5929f3986c55293de,

title = "Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial",

abstract = "Background and Aims: Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to examine the effects of magnesium supplementation on hyperandrogenism, hirsutism, and sleep quality in women with PCOS. Methods: In this parallel randomized clinical trial, 64 women with PCOS were randomly assigned to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. Patients in the magnesium group received one 250 mg magnesium oxide tablet, per day. Hyperandrogenism, hirsutism, and sleep quality were measured at the beginning and end of the study. This randomized clinical trial was registered at https://www.IRCT.ir (IRCT20130903014551N8). Results: Magnesium supplementation had no significant effect on hyperandrogenism (p = 0.51 for dehydroepiandrosterone sulfates, p = 0.27 for testosterone), hirsutism (p = 0.23), and sleep quality (p = 0.85) compared with placebo. Conclusions: The present study showed that a single dose of magnesium supplementation elicited no beneficial effects on the mentioned symptoms in polycystic women. It is possible that the positive effects of magnesium observed in the former studies were due to the synergistic effects of other vitamins or minerals. More studies are needed in this area.",

keywords = "hirsutism, hyperandrogenism, magnesium, polycystic ovarian syndrome, sleep quality",

author = "Mahsa Gholizadeh‐Moghaddam and Hatav Ghasemi‐Tehrani and Gholamreza Askari and Mahsima Jaripur and Clark, {Cain C. T.} and Rouhani, {Mohammad Hossein}",

note = "This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited.{\textcopyright} 2022 The Authors.Health Science Reportspublished by Wiley Periodicals LLC.",

year = "2023",

month = jan,

doi = "10.1002/hsr2.1013",

language = "English",

volume = "6",

journal = "Health Science Reports",

issn = "2398-8835",

publisher = "John Wiley & Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome

T2 - A randomized, placebo‐controlled clinical trial

AU - Gholizadeh‐Moghaddam, Mahsa

AU - Ghasemi‐Tehrani, Hatav

AU - Askari, Gholamreza

AU - Jaripur, Mahsima

AU - Clark, Cain C. T.

AU - Rouhani, Mohammad Hossein

N1 - This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited.© 2022 The Authors.Health Science Reportspublished by Wiley Periodicals LLC.

PY - 2023/1

Y1 - 2023/1

N2 - Background and Aims: Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to examine the effects of magnesium supplementation on hyperandrogenism, hirsutism, and sleep quality in women with PCOS. Methods: In this parallel randomized clinical trial, 64 women with PCOS were randomly assigned to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. Patients in the magnesium group received one 250 mg magnesium oxide tablet, per day. Hyperandrogenism, hirsutism, and sleep quality were measured at the beginning and end of the study. This randomized clinical trial was registered at https://www.IRCT.ir (IRCT20130903014551N8). Results: Magnesium supplementation had no significant effect on hyperandrogenism (p = 0.51 for dehydroepiandrosterone sulfates, p = 0.27 for testosterone), hirsutism (p = 0.23), and sleep quality (p = 0.85) compared with placebo. Conclusions: The present study showed that a single dose of magnesium supplementation elicited no beneficial effects on the mentioned symptoms in polycystic women. It is possible that the positive effects of magnesium observed in the former studies were due to the synergistic effects of other vitamins or minerals. More studies are needed in this area.

AB - Background and Aims: Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to examine the effects of magnesium supplementation on hyperandrogenism, hirsutism, and sleep quality in women with PCOS. Methods: In this parallel randomized clinical trial, 64 women with PCOS were randomly assigned to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. Patients in the magnesium group received one 250 mg magnesium oxide tablet, per day. Hyperandrogenism, hirsutism, and sleep quality were measured at the beginning and end of the study. This randomized clinical trial was registered at https://www.IRCT.ir (IRCT20130903014551N8). Results: Magnesium supplementation had no significant effect on hyperandrogenism (p = 0.51 for dehydroepiandrosterone sulfates, p = 0.27 for testosterone), hirsutism (p = 0.23), and sleep quality (p = 0.85) compared with placebo. Conclusions: The present study showed that a single dose of magnesium supplementation elicited no beneficial effects on the mentioned symptoms in polycystic women. It is possible that the positive effects of magnesium observed in the former studies were due to the synergistic effects of other vitamins or minerals. More studies are needed in this area.

KW - hirsutism

KW - hyperandrogenism

KW - magnesium

KW - polycystic ovarian syndrome

KW - sleep quality

UR - http://www.scopus.com/inward/record.url?scp=85147042985&partnerID=8YFLogxK

U2 - 10.1002/hsr2.1013

DO - 10.1002/hsr2.1013

M3 - Article

SN - 2398-8835

VL - 6

JO - Health Science Reports

JF - Health Science Reports

IS - 1

M1 - e1013

ER -